Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy.
Anastos K, Shi Q, French AL, Levine A, Greenblatt RM, Williams C, DeHovitz J, Delapenha R, Hoover DR. Anastos K, et al. Among authors: greenblatt rm. J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):383-92. doi: 10.1097/00126334-200404010-00008. J Acquir Immune Defic Syndr. 2004. PMID: 15097155
Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women.
Gandhi M, Benet LZ, Bacchetti P, Kalinowski A, Anastos K, Wolfe AR, Young M, Cohen M, Minkoff H, Gange SJ, Greenblatt RM; Women's Interagency HIV Study. Gandhi M, et al. Among authors: greenblatt rm. J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):482-91. doi: 10.1097/qai.0b013e31819c3376. J Acquir Immune Defic Syndr. 2009. PMID: 19408353 Free PMC article.
Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study.
Radtke KK, Bacchetti P, Anastos K, Merenstein D, Crystal H, Karim R, Weber KM, Edmonds A, Sheth AN, Fischl MA, Vance D, Greenblatt RM, Rubin LH. Radtke KK, et al. Among authors: greenblatt rm. J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):202-208. doi: 10.1097/QAI.0000000000001658. J Acquir Immune Defic Syndr. 2018. PMID: 29762344 Free PMC article.
Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study.
Telzak EE, Hershow R, Kalish LA, Hardy WD Jr, Zuckerman E, Levine A, Delapenha R, DeHovitz J, Greenblatt RM, Anastos K. Telzak EE, et al. Among authors: greenblatt rm. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15;19(5):513-8. doi: 10.1097/00042560-199812150-00011. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9859966
Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study.
Kirstein LM, Greenblatt RM, Anastos K, Levine A, French AL, Minkoff H, Silver S, Gange SJ; Women's Interagency HIV Study Collaborative Research Group. Kirstein LM, et al. Among authors: greenblatt rm. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):495-503. doi: 10.1097/00126334-200204150-00010. J Acquir Immune Defic Syndr. 2002. PMID: 11981366
Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease.
Anastos K, Barrón Y, Miotti P, Weiser B, Young M, Hessol N, Greenblatt RM, Cohen M, Augenbraun M, Levine A, Muñoz A; Women's Interagency HIV Study Collaborative Study Group. Anastos K, et al. Among authors: greenblatt rm. Arch Intern Med. 2002 Sep 23;162(17):1973-80. doi: 10.1001/archinte.162.17.1973. Arch Intern Med. 2002. PMID: 12230420
176 results